Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to evaluate a novel VRP.
The primary objective of this study is to determine whether the subjective experience of a novel VRP (DeepDream) will be comparable to a standard dose of psychedelics. This study also looks to compare the subjective experience of DeepDream VRP to other available VR modalities developed to mimic psychedelic subjective experience along with assessing the incidence of VRP adverse effects.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Healthy Volunteer |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Meta Quest 3 | Device | Meta Quest 3 is a virtual reality headset device |
|
| Measure | Description | Time Frame |
|---|---|---|
| Assess subjective experience of novel VRP (DeepDream) comparable to a standard dose of psychedelics. | Subject experience will be assessed using the Altered States of Consciousness Rating Scale. | Day 0 through Day 30 |
| Assess subjective experience of novel VRP (DeepDream) comparable to a standard dose of psychedelics. | Subject experience will be assessed using the Mystical Experience Questionnaire. | Day 0 through Day 30 |
| Assess subjective experience of novel VRP (DeepDream) comparable to a standard dose of psychedelics. | Subject experience will be assessed using the Ego-Dissolution Inventory. | Day 0 through Day 30 |
| Measure | Description | Time Frame |
|---|---|---|
| Assess the incidence of VRP adverse effects, principally virtual reality sickness (VRS) and neck and upper back pain. | The number of adverse events will be assessed through qualitative interviews following VRP viewing. | Day 0 through Day 30 |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Healthy volunteers
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Anahita Bassir Nia, MD | Yale University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Yale University School of Medicine | New Haven | Connecticut | 06510 | United States |
Not provided
Not provided
Not provided
Not provided